Targeting AKT in ER-Positive HER2-Negative Metastatic Breast Cancer: From Molecular Promises to Real Life Pitfalls?

por Mery, Benoîte, Poulard, Coralie, Le Romancer, Muriel, Trédan, Olivier
Publicado 2021

Overcoming resistance to PARP inhibitor in epithelial ovarian cancer, are we ready?

por Ray-Coquard, Isabelle, Vanacker, Hélène, Saux, Olivia Le, Tredan, Olivier
Publicado 2020

Glucocorticoid Receptor: A Multifaceted Actor in Breast Cancer

por Noureddine, Lara Malik, Trédan, Olivier, Hussein, Nader, Badran, Bassam, Le Romancer, Muriel, Poulard, Coralie
Publicado 2021

A Systematic Evaluation of Blood Serum and Plasma Pre-Analytics for Metabolomics Cohort Studies

por Jobard, Elodie, Trédan, Olivier, Postoly, Déborah, André, Fabrice, Martin, Anne-Laure, Elena-Herrmann, Bénédicte, Boyault, Sandrine
Publicado 2016

A serum metabolomic fingerprint of bevacizumab and temsirolimus combination as first-line treatment of metastatic renal cell carcinoma

por Jobard, Elodie, Blanc, Ellen, Négrier, Sylvie, Escudier, Bernard, Gravis, Gwenaelle, Chevreau, Christine, Elena-Herrmann, Bénédicte, Trédan, Olivier
Publicado 2015

Innovative Approach for a Typology of Treatment Sequences in Early Stage HER2 Positive Breast Cancer Patients Treated With Trastuzumab in the French National Hospital Database

por Tredan, Olivier, Laurent, Marie, Gilberg, Melina, Ghorbal, Rim, Vainchtock, Alexandre, Lortet-Tieulent, Joannie, Prodel, Martin, Dupin, Julien
Publicado 2022

New developments in treatment of ovarian carcinoma: focus on trabectedin

por Cassier, Philippe A, Duret, Aude, Trédan, Olivier, Carrabin, Nicolas, Méeus, Pierre, Treilleux, Isabelle, Guastalla, Jean-Paul, Ray-Coquard, Isabelle
Publicado 2010

Activation of rapid oestrogen signalling in aggressive human breast cancers

por Poulard, Coralie, Treilleux, Isabelle, Lavergne, Emilie, Bouchekioua-Bouzaghou, Katia, Goddard-Léon, Sophie, Chabaud, Sylvie, Trédan, Olivier, Corbo, Laura, Le Romancer, Muriel
Publicado 2012

Oestrogen Non-Genomic Signalling is Activated in Tamoxifen-Resistant Breast Cancer

por Poulard, Coralie, Jacquemetton, Julien, Trédan, Olivier, Cohen, Pascale A., Vendrell, Julie, Ghayad, Sandra E., Treilleux, Isabelle, Marangoni, Elisabetta, Le Romancer, Muriel
Publicado 2019

A Digital Solution for an Advanced Breast Tumor Board: Pilot Application Cocreation and Implementation Study

por Hodroj, Khalil, Pellegrin, David, Menard, Cindy, Bachelot, Thomas, Durand, Thierry, Toussaint, Philippe, Dufresne, Armelle, Mery, Benoite, Tredan, Olivier, Goulvent, Thibaut, Heudel, Pierre
Publicado 2023

Role of JMJD6 in Breast Tumourigenesis

por Poulard, Coralie, Rambaud, Juliette, Lavergne, Emilie, Jacquemetton, Julien, Renoir, Jack-Michel, Trédan, Olivier, Chabaud, Sylvie, Treilleux, Isabelle, Corbo, Laura, Romancer, Muriel Le
Publicado 2015

Factors of interrupting chemotherapy in patients with Advanced Non-Small-Cell Lung Cancer

por Belbaraka, Rhizlane, Trédan, Olivier, Ray-Coquard, Isabelle, Chvetzoff, Giselle, Bajard, Agathe, Pérol, David, Ismaili, Nabil, Ismaili, Mohammed, Errihani, Hassan, Bachelot, Thomas, Rebattu, Paul
Publicado 2010

Validation of prognostic scores for survival in cancer patients beyond first-line therapy

por Trédan, Olivier, Ray-Coquard, Isabelle, Chvetzoff, Gisèle, Rebattu, Paul, Bajard, Agathe, Chabaud, Sylvie, Pérol, David, Saba, Chadi, Quiblier, Florent, Blay, Jean-Yves, Bachelot, Thomas
Publicado 2011

The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer

por Choucair, Ali, Pham, Thuy Ha, Omarjee, Soleilmane, Jacquemetton, Julien, Kassem, Loay, Trédan, Olivier, Rambaud, Juliette, Marangoni, Elisabetta, Corbo, Laura, Treilleux, Isabelle, Le Romancer, Muriel
Publicado 2019

Soluble VE-cadherin in metastatic breast cancer: an independent prognostic factor for both progression-free survival and overall survival

por Rochefort, Pauline, Chabaud, Sylvie, Pierga, Jean-Yves, Tredan, Olivier, Brain, Etienne, Bidard, François-Clément, Schiffler, Camille, Polena, Helena, Khalil-Mgharbel, Abir, Vilgrain, Isabelle, Bachelot, Thomas
Publicado 2017

ERα-36 regulates progesterone receptor activity in breast cancer

por Konan, Henri-Philippe, Kassem, Loay, Omarjee, Soleilmane, Surmieliova-Garnès, Ausra, Jacquemetton, Julien, Cascales, Elodie, Rezza, Amélie, Trédan, Olivier, Treilleux, Isabelle, Poulard, Coralie, Le Romancer, Muriel
Publicado 2020

UNICANCER: French prospective cohort study of treatment-related chronic toxicity in women with localised breast cancer (CANTO)

por Vaz-Luis, Ines, Cottu, Paul, Mesleard, Christel, Martin, Anne Laure, Dumas, Agnes, Dauchy, Sarah, Tredan, Olivier, Levy, Christelle, Adnet, Johan, Rousseau Tsangaris, Marina, Andre, Fabrice, Arveux, Patrick
Publicado 2019

Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα (+) breast cancer

por Poulard, Coralie, Ha Pham, Thuy, Drouet, Youenn, Jacquemetton, Julien, Surmielova, Ausra, Kassem, Loay, Mery, Benoite, Lasset, Christine, Reboulet, Jonathan, Treilleux, Isabelle, Marangoni, Elisabetta, Trédan, Olivier, Le Romancer, Muriel
Publicado 2023

Therapeutic relevance of molecular screening program in patients with metastatic sarcoma: Analysis from the ProfiLER 01 trial

por Arnaud-Coffin, Patrick, Brahmi, Mehdi, Vanacker, Hélène, Eberst, Lauriane, Tredan, Olivier, Attignon, Valery, Pissaloux, Daniel, Sohier, Emilie, Cassier, Philippe, Garin, Gwenaelle, Pérol, David, Blay, Jean-Yves, Dufresne, Armelle
Publicado 2020

Impact of Physical Activity on Oxidative Stress Markers in Patients with Metastatic Breast Cancer

por Delrieu, Lidia, Touillaud, Marina, Pérol, Olivia, Morelle, Magali, Martin, Agnès, Friedenreich, Christine M., Mury, Pauline, Dufresne, Armelle, Bachelot, Thomas, Heudel, Pierre-Etienne, Fervers, Béatrice, Trédan, Olivier, Pialoux, Vincent
Publicado 2021